MaxCyte MXCT Business Segments — D&A

Similar metrics at other companies

DUOTTechnologies — D&A

$101.89K-38.0%

SMP

SMPEngineered Solutions — D&A

$2.59M+3.8%

ASSTMedical Device — D&A

$32K—

HXLEngineered Products — D&A

$3.2M0.0%

EXPOEngineering And Other Scientific — D&A

$1.85M+1.3%

AMPGManufacturing And Engineering — D&A

$314.62K+237%

Questions, answered.

What is MaxCyte's business segments — D&A?

MaxCyte (MXCT) reported business segments — D&A of $1.02M in Q1 2026.

How has MaxCyte's business segments — D&A changed year-over-year?

MaxCyte's business segments — D&A decreased by 4.2% year-over-year, from $1.06M to $1.02M.

What is the long-term trend for MaxCyte's business segments — D&A?

Over 2 years (2023 to 2025), MaxCyte's business segments — D&A has grown at a 3.0% compound annual growth rate (CAGR), from $3.99M to $4.23M.

What does business segments — D&A mean?

Represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the segment. This metric is used to understand the capital intensity of the business and the ongoing investment in infrastructure.